Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Urinary Bladder Neoplasms × Injections × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 20 Myelodysplastic Syndromes 8 Leukemia, Myelomonocytic, Chronic 7 Carcinoma, Non-Small-Cell Lung 7 Advanced Solid Tumor 6 Triple Negative Breast Neoplasms 4 Solid Tumor 4 Neoplasms 4 Myeloproliferative Disorders 4 Breast Neoplasms 4 Advanced Solid Tumour 4 Advanced Solid Tumors 4 Sarcoma 2 Recurrence 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Myelodysplastic-Myeloproliferative Diseases 2 Multiple Myeloma 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, Monocytic, Acute 2 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Biliary Tract Neoplasms 2 Uterine Cervical Neoplasms 1 Tuberous Sclerosis 1 Thrombocythemia, Essential 1

Interventions

Gemcitabine 26 pembrolizumab 19 Cisplatin 19 Specimen Handling 15 Magnetic Resonance Spectroscopy 15 durvalumab 11 enfortumab vedotin 9 Nivolumab 9 avelumab 8 atezolizumab 7 Cystectomy 7 Carboplatin 7 Mitomycin 6 Docetaxel 6 Cystoscopy 6 Radiation 5 Paclitaxel 5 Biopsy 5 sacituzumab govitecan 4 Transurethral Resection of Bladder 4 Standard of Care 4 Radiotherapy 4 Ipilimumab 4 Fluorouracil 4 erdafitinib 3 dehydroftorafur 3 cabozantinib 3 Practice Guidelines as Topic 3 Platinum 3 Mitozytrex 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡